Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3666 | 1857 | 27.2 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
310 | 17755 | CARCINOMA RENAL CELL//PARTIAL NEPHRECTOMY//NEPHRECTOMY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DE NOVO MALIGNANCIES | Author keyword | 15 | 88% | 0% | 7 |
2 | DONOR MALIGNANCY | Author keyword | 12 | 86% | 0% | 6 |
3 | TUMOR TRANSMISSION | Author keyword | 12 | 86% | 0% | 6 |
4 | ORGAN TRANSPLANT RECIPIENTS | Author keyword | 7 | 39% | 1% | 14 |
5 | DE NOVO TUMORS | Author keyword | 6 | 71% | 0% | 5 |
6 | POST TRANSPLANT MALIGNANCIES | Author keyword | 6 | 100% | 0% | 4 |
7 | POST TRANSPLANT MALIGNANCY | Author keyword | 6 | 50% | 0% | 8 |
8 | CANCER TRANSMISSION | Author keyword | 5 | 63% | 0% | 5 |
9 | POSTTRANSPLANT MALIGNANCIES | Author keyword | 4 | 67% | 0% | 4 |
10 | ALLOGRAFT KIDNEY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DE NOVO MALIGNANCIES | 78 | 64% | 4% | 77 |
2 | ALLOGRAFT KIDNEY | 22 | 81% | 1% | 13 |
3 | DE NOVO MALIGNANCY | 15 | 88% | 0% | 7 |
4 | DE NOVO CANCER | 14 | 100% | 0% | 7 |
5 | TRANSPLANT TUMOR REGISTRY | 13 | 67% | 1% | 12 |
6 | POSTTRANSPLANT MALIGNANCY | 11 | 78% | 0% | 7 |
7 | POSTTRANSPLANT MALIGNANCIES | 8 | 75% | 0% | 6 |
8 | LONG TERM IMMUNOSUPPRESSION | 8 | 44% | 1% | 14 |
9 | HOMOGRAFT RECIPIENTS | 7 | 67% | 0% | 6 |
10 | ROMAGNA REGION EXPERIENCE | 6 | 80% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Medical progress - Skin cancers after organ transplantation | 2003 | 562 | 84 | 48% |
Skin cancer in organ transplant recipients - Where do we stand today ? | 2008 | 82 | 30 | 83% |
Cancer incidence and risk factors after solid organ transplantation | 2009 | 104 | 92 | 57% |
Liver transplantation: immunosuppression and oncology | 2014 | 9 | 64 | 33% |
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management | 2002 | 270 | 124 | 50% |
Extracranial glioblastoma in transplant recipients | 2014 | 2 | 15 | 87% |
Incidence, Risk Factors, and Preventative Management of Skin Cancers in Organ Transplant Recipients: A Review of Single- and Multicenter Retrospective Studies from 2006 to 2010 | 2013 | 9 | 109 | 62% |
The Role of mTOR Inhibitors in the Management of Posttransplant Malignancy | 2009 | 56 | 70 | 46% |
Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review | 2014 | 2 | 27 | 70% |
Immunosuppressive therapy and malignancy in organ transplant recipients - A systematic review | 2007 | 113 | 191 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIAGNOST MOL PATOL CARDIOVASC TR IANTI | 4 | 75% | 0.2% | 3 |
2 | UNITA NEFROL DIALISI TER IA TR IANTO RENALE | 4 | 75% | 0.2% | 3 |
3 | ISRAEL PENN INT TRANSPLANT TUMOR REGISTRY | 3 | 50% | 0.3% | 5 |
4 | DIP MALATTIE INFETT | 2 | 67% | 0.1% | 2 |
5 | SERV NEFROL TRANSPLANTAMENT RENAL | 2 | 67% | 0.1% | 2 |
6 | SURG UREM DIABET PATIENT | 2 | 67% | 0.1% | 2 |
7 | AUSTRALIA NEW ZEALAND DIALYSIS TRANSPLANT REG | 2 | 22% | 0.4% | 8 |
8 | AUSTRALIA NEW ZEALAND LIVER TRANSPLANT REGISTRY | 1 | 100% | 0.1% | 2 |
9 | DIP EPIDEMIOL | 1 | 100% | 0.1% | 2 |
10 | RIFERIMENTO TR IANTI EMILIA ROMAGNA | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204445 | ACQUIRED CYSTIC KIDNEY DISEASE//ACQUIRED RENAL CYSTIC DISEASE//ACQUIRED CYSTIC DISEASE |
2 | 0.0000189030 | CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN |
3 | 0.0000141870 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE |
4 | 0.0000083836 | EPIDERMODYSPLASIA VERRUCIFORMIS//BETAPAPILLOMAVIRUS//BOWENOID IN SITU CARCINOMA |
5 | 0.0000055646 | SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS |
6 | 0.0000050251 | BASAL CELL CARCINOMA//MOHS MICROGRAPHIC SURGERY//BASOSQUAMOUS CARCINOMA |
7 | 0.0000046883 | MED CHILDRENS HOSP FDN//PEDIAT SURG 219 BRYANT ST//PESQUISA SOBRE TIMO |
8 | 0.0000045734 | KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KAPOSI SARCOMA |
9 | 0.0000039408 | IMIQUIMOD//ACTINIC KERATOSES//ACTINIC CHEILITIS |
10 | 0.0000036321 | ACRODERMATITIS CONTINUA OF HALLOPEAU//VOCLOSPORIN//MICROEMULSION FORMULATION |